Immediate reduction of white blood cell count after tocilizumab administration was observed in some cases.
Nagamine
Ryuji
R
Department of Orthopaedic Surgery, Yoshizuka Hayashi Hospital, Hakata-ku, Fukuoka, Japan. r_nagamine@kyorinkai.or.jp
Chen
Weijia
W
Hara
Toshihiko
T
Kondo
Keiichi
K
Sugioka
Yoichi
Y
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D015331:Cohort Studies; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced*; D008875:Middle Aged; D019947:Receptors, Interleukin-6 / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D019947:Receptors, Interleukin-6; C502936:tocilizumab